Guardant Health, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 41.91 M

Guardant Health, Inc. Depreciation And Amortization is USD 41.91 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -3.09% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Guardant Health, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 43.25 M, a 10.59% change year over year.
  • Guardant Health, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 39.11 M, a 59.86% change year over year.
  • Guardant Health, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 24.46 M, a 50.30% change year over year.
  • Guardant Health, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 16.27 M, a 1.37% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased